Neonatal lupus erythematosus is associated with cutaneous lesions, CHB, hepatic disease, and thrombocytopenia. IgG antibodies to Ro and/or La cross the placenta and participate in the development ...

The treatment for the cutaneous lesions is strict sun avoidance and mid to low-potency topical steroids. Systemic steroids are not required for managing cutaneous lesions. Systemic antimalarial ...

There is no guarantee that everyone taking these drugs will get lupus. Neonatal Lupus: Infants who are born from women with lupus can be affected by this very rare type. Its most severe symptom is ...

We're seeking views from healthcare professionals and the public on draft recommendations covering assessments and interventions to reduce the risk of falls in older people. For the first time, NICE ...

Sept 30 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid ...

Now, the company has hit the brakes on its phase 2b study of the drug in lupus nephritis following four patient fatalities. An independent data monitoring committee (IDMC) recommended suspending ...

We’re always considering these risk factors for hospital-acquired sepsis. Newborns are particularly vulnerable to sepsis; what are some of the challenges concerning neonatal sepsis diagnosis and ...

in which some people develop lupus symptoms due to taking medication for another disease. Usually, these symptoms disappear after stopping the medication. The third type is neonatal lupus, which ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN). Gazyva is an engineered humanized monoclonal antibody ...

The Lupus Research Alliance (LRA ... in the final week of pregnancy and an increased risk of stillbirth and early neonatal mortality. Research reveals that gestational exposure to air pollution ...

Systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD, a group of intestinal disorders that cause inflammation of the digestive tract) share a common set of microbiome features that ...